KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 246 filers reported holding KRYSTAL BIOTECH INC in Q2 2024. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $11,887,807 | -24.2% | 101,259 | -48.3% | 0.93% | -34.0% |
| Q1 2023 | $15,690,159 | -58.2% | 195,980 | -58.6% | 1.41% | -59.4% |
| Q4 2022 | $37,525,801 | +9.3% | 473,691 | -3.8% | 3.48% | +0.3% |
| Q3 2022 | $34,331,000 | -12.2% | 492,555 | -17.3% | 3.47% | -23.7% |
| Q2 2022 | $39,108,000 | -18.1% | 595,612 | -17.0% | 4.55% | +8.0% |
| Q1 2022 | $47,771,000 | +0.4% | 717,936 | +5.6% | 4.21% | +23.7% |
| Q4 2021 | $47,578,000 | +43.9% | 680,170 | +7.4% | 3.41% | +56.4% |
| Q3 2021 | $33,074,000 | -7.6% | 633,481 | +20.3% | 2.18% | +1.4% |
| Q2 2021 | $35,812,000 | -5.4% | 526,650 | +7.1% | 2.15% | -14.5% |
| Q1 2021 | $37,866,000 | +28.3% | 491,511 | -0.0% | 2.51% | +15.0% |
| Q4 2020 | $29,504,000 | +47.5% | 491,740 | +5.8% | 2.18% | +6.5% |
| Q3 2020 | $20,004,000 | +4.0% | 464,663 | +0.1% | 2.05% | -8.5% |
| Q2 2020 | $19,226,000 | – | 464,179 | – | 2.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 771,250 | $53,949,000 | 4.15% |
| First Light Asset Management, LLC | 680,170 | $47,578,000 | 3.41% |
| ACT CAPITAL MANAGEMENT, LLC | 59,000 | $4,127,000 | 2.98% |
| S Squared Technology, LLC | 95,215 | $6,660,000 | 2.98% |
| Redmile Group, LLC | 1,820,898 | $127,372,000 | 2.90% |
| Soleus Capital Management, L.P. | 228,437 | $15,979,000 | 1.60% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 50,922 | $3,562,000 | 1.59% |
| Artal Group S.A. | 700,000 | $48,965,000 | 1.33% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 46,670 | $3,265,000 | 1.32% |
| Kynam Capital Management, LP | 34,816 | $2,435,000 | 1.30% |